Brian Zikmund-Fisher
@bzikmund.bsky.social
200 followers 79 following 11 posts
Professor @ UMich. Research making health & risk data communications intuitively meaningful, narratives, improv. Editor-in-Chief of Medical Decision Making & MDM Policy & Practice. Opinions my own.
Posts Media Videos Starter Packs
bzikmund.bsky.social
Put simply, no. But anyone can improve their communications by being very intentional. What do you want the person to think, feel, or do immediately upon receipt of the number? Let that guide the selection of format.
bzikmund.bsky.social
Depends on a) what kind of number / what kind of visual and b) what you mean by "better". As I and my co-authors discuss here (doi.org/10.1093/jami...), there are at least 12-14 different outcomes of number communication, and no format is best at all of them.
Do you want to promote recall, perceptions, or behavior? The best data visualization depends on the communication goal
Abstract. Data visualizations can be effective and inclusive means for helping people understand health-related data. Yet numerous high-quality studies com
doi.org
bzikmund.bsky.social
Very proud of authoring this JAMA piece summarizing the most evidence based recommendations we have about communicating probabilities and test results to patients. Now to hope that people believe that using these best practices matters!
jama.com
JAMA @jama.com · 14d
Clinicians can enhance patient understanding by using numerical data instead of verbal probabilities, consistent denominators, absolute risk comparisons, and clear context for unfamiliar data types.

ja.ma/4pAC3zi
JAMA Insights: How to Communicate Medical Numbers. It outlines recommendations for conveying risk, adjusting numerators, communicating probability changes, using visualizations, and providing context, with examples of problematic and preferred communication styles.
bzikmund.bsky.social
Thanks, @mcpoliti.bsky.social! We hope that people can accept the challenging idea that there is no "best" way to communicate risk because EVERY approach improves some outcomes but diminishes others. We have to make a new choice each time we communicate, and we must know our goals to do so.
bzikmund.bsky.social
The Making Numbers Meaningful Systematic Review papers are now available! Review of 316 papers on communicating health-related probabilities to the public. 1,119 findings. Methods / scoping paper, 6 evidence summary papers, 5 editorials. All open access.
journals.sagepub.com/topic/collec...
Special Collection: "The Making Numbers Meaningful Systematic Review" - MDM Policy & Practice
Reposted by Brian Zikmund-Fisher
smdm.bsky.social
🎉 Meet the Member: Brian! 🎉

🧠 Area of Expertise: Risk Communication & Shared Decision-Making

🎭 Fun Fact: Uses improv theater games to enhance teaching, research presentations, and communication skills!

Brian has been an SMDM member since 2000 and deeply values its mentoring culture. 💙
bzikmund.bsky.social
Great to see my friend and colleague @ldscherer.bsky.social and Kirsten McCaffery from @sydneyhealthlitlab.bsky.social in today's New York Times talking about how calling something "cancer" may not be helpful for decision making about DCIS!

Tagging @smdm.bsky.social for amplification.
When ‘Cancer’ Gets in the Way of Treatment
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
www.nytimes.com
bzikmund.bsky.social
Great discussion by my colleague @kaytesb.bsky.social on what actually happens to direct-to-consumer genetic testing data.
jama.com
JAMA @jama.com · Jan 9
Many who undergo direct-to-consumer genetic testing don’t realize that their data are being licensed to pharmaceutical and biotech companies.

JAMA Viewpoint authors @kaytesb.bsky.social and Anya E. R. Prince discuss this gap between consumer expectations and what is being done.

ja.ma/40uGL7q
bzikmund.bsky.social
I'm pleased to announce that the supplements are now fixed and available for download at JAMA!
bzikmund.bsky.social
Unfortunately, JAMA messed up the publication of the supplements. They're fixing it now, should be available online fairly soon. In the meantime, while we can't post them, we can send them directly to anyone who reaches out directly to Dr. Lapedis or me.
bzikmund.bsky.social
Thanks for the callout, @iwashyna.bsky.social! I hope this convinces people that it's simply unethical not to provide a patient-friendly, plain language summary like our PCPR format, given that patients have direct access to these reports in their records.
bzikmund.bsky.social
I've published literally hundreds of studies, but this one will always be special. I'm so proud to have helped Dr. Cathryn Lapedis show so convincingly how BAD current prostate biopsy pathology reports are compared to a simple patient-centered design. PLUS: my first JAMA article ever!
jama.com
JAMA @jama.com · Jan 2
Patient-centered pathology reports improved patients' understanding of prostate biopsy results and their ability to accurately assess their cancer diagnosis and risk level, compared to standard pathology reports.

ja.ma/4a3c38z